Recall of Device Recall DiaSorin AntiCardiolipin IgA ELISA Kit,

According to U.S. Food and Drug Administration, this recall involved a device in United States that was produced by Diasorin Inc..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    30950
  • Event Risk Class
    Class 3
  • Event Number
    Z-0927-05
  • Event Initiated Date
    2004-11-01
  • Event Date Posted
    2005-06-25
  • Event Status
    Terminated
  • Event Country
  • Event Terminated Date
    2006-07-22
  • Event Source
    USFDA
  • Event Source URL
  • Notes / Alerts
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Extra notes in the data
    System, Test, Anticardiolipin Immunological - Product Code MID
  • Reason
    Diasorin anti-cardiolipin iga kit, catalog no. 7800, positive control was on the low limit of the acceptable range (16-35 u/ml).
  • Action
    Customers were notifed of the product and the problem and were advised to destroy any remaining inventory and replacements were offered.

Device

  • Model / Serial
    Catalog no. 7800, lots FS1123 and FS2184
  • Product Classification
  • Device Class
    2
  • Implanted device?
    No
  • Distribution
    NY, KS, GA & MT
  • Product Description
    DiaSorin Anti-Cardiolipin IgA ELISA Kit, catalog no. 7800. Manufactured for: DiaSorin Inc. 1951 Northwestern Avenue, Stillwater, MN 55082. Made in the United Kingdom.
  • Manufacturer

Manufacturer

  • Manufacturer Address
    Diasorin Inc., 1951 Northwestern Ave S, Stillwater MN 55082-7536
  • Manufacturer Parent Company (2017)
  • Source
    USFDA